Healthcare Value Capital, LLC Buys Gilead Sciences Inc, Viking Therapeutics Inc, Allergan PLC, Sells Fluidigm Corp, ProShares UltraShort Nasdaq Biotechnology

• New Purchases: GILD, ADMS,
• Added Positions: VKTX, AGN,
• Sold Out: FLDM, BIS,

For the details of Healthcare Value Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/healthcare+value+capital%2C+llc/current-portfolio/portfolio

1. Allergan PLC (AGN) - 30,000 shares, 16.92% of the total portfolio. Shares added by 50.00%
2. GlaxoSmithKline PLC (GSK) - 100,000 shares, 16.10% of the total portfolio.
3. Tyme Technologies Inc (TYME) - 2,175,000 shares, 14.75% of the total portfolio.
4. Gilead Sciences Inc (GILD) - 50,000 shares, 12.53% of the total portfolio. New Position
5. Ligand Pharmaceuticals Inc (LGND) - 25,000 shares, 12.11% of the total portfolio.

Healthcare Value Capital, LLC initiated holding in Gilead Sciences Inc. The purchase prices were between $62.53 and $70.05, with an estimated average price of $66.46. The stock is now traded at around $65.08. The impact to a portfolio due to this purchase was 12.53%. The holding were 50,000 shares as of .

Healthcare Value Capital, LLC initiated holding in Adamas Pharmaceuticals Inc. The purchase prices were between $7.11 and $12.15, with an estimated average price of $9.01. The stock is now traded at around $5.49. The impact to a portfolio due to this purchase was 2.74%. The holding were 100,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Viking Therapeutics Inc by 150.00%. The purchase prices were between $7.58 and $9.94, with an estimated average price of $8.38. The stock is now traded at around $8.39. The impact to a portfolio due to this purchase was 5.74%. The holding were 250,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Allergan PLC by 50.00%. The purchase prices were between $132.09 and $160.79, with an estimated average price of $144.95. The stock is now traded at around $135.96. The impact to a portfolio due to this purchase was 5.64%. The holding were 30,000 shares as of .

Healthcare Value Capital, LLC sold out a holding in Fluidigm Corp. The sale prices were between $8.47 and $14.36, with an estimated average price of $10.48.

Healthcare Value Capital, LLC sold out a holding in ProShares UltraShort Nasdaq Biotechnology. The sale prices were between $15.96 and $23.1, with an estimated average price of $17.73.